Question · asked by 1 review

Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors: Serious adverse events

Population
erectile dysfunction in men with obstructive sleep apnoea
Intervention
Continuous positive airway pressure (CPAP)
Comparison
phosphodiesterase type 5 inhibitors
Outcome
Serious adverse events

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors
Serious adverse events · erectile dysfunction in men with obstructive sleep apnoea
Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive… (2021) · Cochrane Headline outcomes only
no estimate extracted1 study · 40 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea
2021 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.